A detailed history of Koshinski Asset Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 6,611 shares of AZN stock, worth $444,126. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,611
Previous 6,831 3.22%
Holding current value
$444,126
Previous $532,000 3.2%
% of portfolio
0.05%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$76.67 - $87.62 $16,867 - $19,276
-220 Reduced 3.22%
6,611 $515,000
Q2 2024

Jul 12, 2024

BUY
$66.81 - $80.83 $146,247 - $176,936
2,189 Added 47.16%
6,831 $532,000
Q1 2024

May 08, 2024

SELL
$61.03 - $69.57 $30,820 - $35,132
-505 Reduced 9.81%
4,642 $314,000
Q4 2023

Jan 29, 2024

SELL
$61.89 - $69.28 $86,831 - $97,199
-1,403 Reduced 21.42%
5,147 $346,000
Q3 2023

Oct 18, 2023

BUY
$64.85 - $71.7 $424,767 - $469,635
6,550 New
6,550 $443,000
Q2 2022

Jul 12, 2022

SELL
$59.26 - $71.14 $126,934 - $152,381
-2,142 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$55.72 - $67.12 $4,680 - $5,638
84 Added 4.08%
2,142 $142 Million
Q4 2021

Jan 14, 2022

SELL
$54.02 - $63.83 $2,538 - $3,000
-47 Reduced 2.23%
2,058 $120 Million
Q3 2021

Oct 12, 2021

BUY
$55.56 - $60.79 $116,953 - $127,962
2,105 New
2,105 $126,000
Q2 2021

Jul 26, 2021

SELL
$48.42 - $60.18 $341,748 - $424,750
-7,058 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$47.16 - $54.44 $1.01 Million - $1.17 Million
-21,454 Reduced 75.25%
7,058 $206,000
Q4 2020

Feb 02, 2021

BUY
$48.52 - $58.02 $1.16 Million - $1.39 Million
23,905 Added 518.88%
28,512 $915,000
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $110,704 - $127,454
-2,086 Reduced 31.17%
4,607 $255,000
Q2 2020

Jul 29, 2020

BUY
$43.1 - $55.31 $288,468 - $370,189
6,693 New
6,693 $354,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.